Association Between the Presence of Pulmonary Hypertension Before Cardiovascular Surgery and the Nephroprotective Effect of Carperitide: A Retrospective Cohort Study

• Published in: Curēus (Palo Alto, CA) Vol. 14; no. 3; p. e22891
• Main Authors: Suzuki, Shin, Aoki, Yoshitaka, Anezaki, Hiroki, Wakuda, Chiharu, Oshima, Shinji, Nishimoto, Hisako, Kobayashi, Atsushi, Kato, Hiromi, Doi, Matsuyuki, Nakajima, Yoshiki
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 06.03.2022; Cureus
• Subjects: Anesthesiology; Body mass index; Cardiac catheterization; Cohort analysis; Creatinine; Drug dosages; Heart surgery; Hospitals; Intensive care; Intubation; Mortality; Nephrology; Physiology; Preventive Medicine; Pulmonary arteries; Pulmonary hypertension; Review boards; Sensitivity analysis; Urine; Veins & arteries; Japan; creatinine; renal replacement therapy; urine; pulmonary hypertension; acute kidney injury; carperitide; atrial natriuretic peptide
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.22891

Introduction We hypothesized that the nephroprotective and diuretic effects of carperitide are effective in patients with pulmonary hypertension. We examined the presence of preoperative pulmonary hypertension and the effects of carperitide. Methods In this retrospective cohort study, we included patients aged 20 years or older who received carperitide during cardiovascular surgery and were admitted to the postoperative intensive care unit. We used hospital data from March 2019 to September 2021. The outcomes were the incidence of acute kidney injury, the number of patients using renal replacement therapy in the intensive care unit, urine volume in the first 24 hours after surgery, and the difference in serum creatinine concentrations between before and after surgery. After adjusting for confounding factors by multivariate analysis, we compared the difference in outcomes with and without preoperative pulmonary hypertension (systolic pulmonary artery pressure ≥36 mmHg). Results The study included 244 patients, with 72 (29.5%) in the pulmonary hypertension group and 172 (70.5%) in the control group. Acute kidney injury occurred in eight (11.1%) patients in the pulmonary hypertension group and in 18 (10.5%) patients in the control group, with no significant difference by logistic regression analysis (odds ratio 1.40, 95% confidence interval 0.54-3.62, p=0.49). Additionally, the use of renal replacement therapy, urine volume at 24 hours postoperatively, and the difference in serum creatinine concentrations were not different between the two groups. Conclusions Our results suggest that the effect of carperitide during cardiovascular surgery is not affected by the presence or absence of pulmonary hypertension.